Kate Dier

Kate Dier currently serves as the Director of Finance at Thermo Fisher Scientific, where she plays a pivotal role in steering the financial strategy and operational excellence of the Ion Chromatography business unit. In this capacity, Kate leverages her extensive expertise in financial analysis, budgeting, and financial modeling to drive sustainable growth and optimize resource allocation within a highly complex, matrixed organization. Her deep understanding of industry-specific financial drivers enables her to develop accurate bottoms-up budgets, manage investment priorities, and monitor cost targets effectively, ensuring alignment with the company's strategic objectives.

A key aspect of Kate’s role involves collaborating cross-functionally with R&D, manufacturing, and commercial teams to translate business insights into actionable financial plans. She utilizes advanced tools such as Hyperion and HFM to streamline financial reporting and enhance data accuracy, facilitating timely decision-making. Her proficiency in inventory management and financial analysis allows her to identify key performance indicators, assess operational efficiencies, and recommend process improvements that contribute to the business unit’s profitability.

Kate’s leadership extends beyond traditional finance functions; she actively participates in strategic initiatives, providing critical financial insights that shape product development and go-to-market strategies. Her ability to communicate complex financial results and recommendations clearly to both technical and non-technical stakeholders has been instrumental in fostering a collaborative environment. With her comprehensive skill set and industry-specific knowledge, Kate Dier continues to add significant value to Thermo Fisher Scientific’s Ion Chromatography division, supporting its mission to deliver innovative analytical solutions to customers worldwide.